J 2020

European Society for Immunodeficiencies (ESID) and European Reference Network on Rare Primary Immunodeficiency, Autoinflammatory and Autoimmune Diseases (ERN RITA) Complement Guideline: Deficiencies, Diagnosis, and Management

BRODSZKI, Nicholas, Ashley FRAZER-ABEL, Anete S. GRUMACH, Anete S. KIRSCHFINK, Jiří LITZMAN et. al.

Basic information

Original name

European Society for Immunodeficiencies (ESID) and European Reference Network on Rare Primary Immunodeficiency, Autoinflammatory and Autoimmune Diseases (ERN RITA) Complement Guideline: Deficiencies, Diagnosis, and Management

Authors

BRODSZKI, Nicholas (752 Sweden), Ashley FRAZER-ABEL (840 United States of America), Anete S. GRUMACH (76 Brazil), Anete S. KIRSCHFINK (276 Germany), Jiří LITZMAN (203 Czech Republic, belonging to the institution), Elena PEREZ (840 United States of America), Mikko R. J. SEPPANEN (246 Finland), Kathleen E. SULLIVAN (840 United States of America) and Stephen JOLLES (826 United Kingdom of Great Britain and Northern Ireland, guarantor)

Edition

Journal of Clinical Immunology, New York, Springer, 2020, 0271-9142

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30102 Immunology

Country of publisher

United States of America

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

Impact factor

Impact factor: 8.317

RIV identification code

RIV/00216224:14110/20:00116025

Organization unit

Faculty of Medicine

UT WoS

000516182000001

Keywords in English

Complement; complement deficiencies; classical pathway; alternative pathway; mannan-binding lectin

Tags

Tags

International impact, Reviewed
Změněno: 17/7/2020 09:41, Mgr. Tereza Miškechová

Abstract

V originále

This guideline aims to describe the complement system and the functions of the constituent pathways, with particular focus on primary immunodeficiencies (PIDs) and their diagnosis and management. The complement system is a crucial part of the innate immune system, with multiple membrane-bound and soluble components. There are three distinct enzymatic cascade pathways within the complement system, the classical, alternative and lectin pathways, which converge with the cleavage of central C3. Complement deficiencies account for similar to 5% of PIDs. The clinical consequences of inherited defects in the complement system are protean and include increased susceptibility to infection, autoimmune diseases (e.g., systemic lupus erythematosus), age-related macular degeneration, renal disorders (e.g., atypical hemolytic uremic syndrome) and angioedema. Modern complement analysis allows an in-depth insight into the functional and molecular basis of nearly all complement deficiencies. However, therapeutic options remain relatively limited for the majority of complement deficiencies with the exception of hereditary angioedema and inhibition of an overactivated complement system in regulation defects. Current management strategies for complement disorders associated with infection include education, family testing, vaccinations, antibiotics and emergency planning.